Background: Genome-wide association studies have identified robust susceptibility loci associated with lung cancer. As part of the OncoArray-TRICL consortium, we have recently completed the largest GWAS on lung cancer including 29,266 cases and 56,450 controls of European descent. The goal of this study is to integrate the complete GWAS results with a large-scale expression quantitative trait loci (eQTL) mapping study in human lung tissues (n¼1,038) to identify candidate causal genes for lung cancer. Method: Transcriptome-wide association study (TWAS) was used to integrate GWAS and lung eQTL signals and identify genes whose levels of expression in lung tissue are causally related to lung cancer. TWAS was performed on six histological and smoking subgroups, namely overall lung cancer, adenocarcinoma, squamous cell carcinoma, small cell carcinoma, never-smokers, and ever-smokers. Result: As expected, the main TWAS signal for all histological subtypes and ever-smokers was on chromosome 15q25. The genes most strongly associated with lung cancer at this locus were IREB2(P TWAS ¼4.97E-104), and to a lower extent, CHRNA5(P TWAS ¼5.26E-20) and HYKK(P TWAS ¼2.04E-17). TWAS identified causal genes were different from those reported in GWAS including JAMLon 11q23.3 in overall lung cancer (P TWAS ¼1.39E-6) and adenocarcinoma (P TWAS ¼2.09E-8),NOTCH4on 6p21.32 in squamous cell carcinoma (P TWAS ¼1.24E-12), ZNRD1on 6p22.1 in overall lung cancer (P TWAS ¼3.41E-14) and ever-smokers (P TWAS ¼1.29E-9), HIST1H2BDon 6p22.2 for small cell carcinoma (P TWAS ¼1.54E-6), and NEXNon 1p31.1 in never-smokers (P TWAS ¼2.64E-5). In addition, a new small cell carcinoma susceptibility locus was identified on 4q32.2 and associated with the expression levels of TMA16(P TWAS ¼4.2E-6). Conclusion: In conclusion, lung tissue TWAS on lung cancer, histological subtypes and smoking subgroups revealed novel causal genes in GWAS-nominated loci. A new locus for small cell carcinoma (4q32.2-TMA16) was also identified and will require further validation.
Background: Genome-wide association studies have identified robust susceptibility loci associated with lung cancer. As part of the OncoArray-TRICL consortium, we have recently completed the largest GWAS on lung cancer including 29,266 cases and 56,450 controls of European descent. The goal of this study is to integrate the complete GWAS results with a large-scale expression quantitative trait loci (eQTL) mapping study in human lung tissues (n¼1,038) to identify candidate causal genes for lung cancer. Method: Transcriptome-wide association study (TWAS) was used to integrate GWAS and lung eQTL signals and identify genes whose levels of expression in lung tissue are causally related to lung cancer. TWAS was performed on six histological and smoking subgroups, namely overall lung cancer, adenocarcinoma, squamous cell carcinoma, small cell carcinoma, never-smokers, and ever-smokers. Result: As expected, the main TWAS signal for all histological subtypes and ever-smokers was on chromosome 15q25. The genes most strongly associated with lung cancer at this locus were IREB2(P TWAS ¼4.97E-104), and to a lower extent, CHRNA5(P TWAS ¼5. 26E-20) and HYKK(P TWAS ¼2.04E-17). TWAS identified causal genes were different from those reported in GWAS including JAMLon 11q23.3 in overall lung cancer (P TWAS ¼1.39E-6) and adenocarcinoma (P TWAS ¼2.09E-8),NOTCH4on 6p21.32 in squamous cell carcinoma (P TWAS ¼1.24E-12), ZNRD1on 6p22.1 in overall lung cancer (P TWAS ¼3.41E-14) and ever-smokers (P TWAS ¼1.29E-9), HIST1H2BDon 6p22.2 for small cell carcinoma (P TWAS ¼1.54E-6), and NEXNon 1p31.1 in never-smokers (P TWAS ¼2.64E-5). In addition, a new small cell carcinoma susceptibility locus was identified on 4q32.2 and associated with the expression levels of TMA16(P TWAS ¼4.2E-6). Conclusion: In conclusion, lung tissue TWAS on lung cancer, histological subtypes and smoking subgroups revealed novel causal genes in GWAS-nominated loci. A new locus for small cell carcinoma (4q32.2-TMA16) was also identified and will require further validation. Keywords: TWAS, lung cancer, Genomics MA03.10 Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer L. Cannon-Albright, 1 W. Akerley, 2 S. Carr 3 1 Internal Medicine, University of Utah, Salt Lake City, UT/US, 2 Huntsman Cancer Institute, Salt Lake City, UT/US, 3 Thoracic Surgery, University of Maryland School of Medicine, Baltimore, MD/US Background: Published risk estimates for diagnosis of lung cancer based on family history are typically focused on close relatives, rather than a more diverse or complete family history. This study provides relative risks (RR) for lung cancer based on comprehensive family history data obtained from a statewide Cancer Registry linked to a high quality genealogy data resource. Risk estimates presented avoid common recall, recruitment, ascertainment biases, and are based on an individual's (proband's) lung cancer family history constellation (pattern of lung cancer affected relatives). Method: A population-based genealogical resource linked to a statewide electronic SEER cancer registry estimated relative risk (RR) for lung cancer for an individual based upon their lung cancer family history. Family history data available for a proband included degree of relationship (first to thirddegree), paternal or maternal family lung cancer history, number of lung cancer affected relatives and age at diagnosis of affected relatives. Over 1.3M probands probands with specific constellations of lung cancer were analyzed. To estimate RRs, the observed number of lung cancer cases among probands with a specific family history constellation was compared to the expected number using internal cohortspecific rates. Result: 5,048 lung cancer cases were identified. Significantly elevated RR was observed for any number of lung-canceraffected relatives among first-, second-, or third-degree relatives. RRs for lung cancer were significantly elevated for each additional lung cancer first-degree relative (FDR) ranging from RR¼2.57 (2.39, 2.76) for >¼ 1 FDR to RR¼4.24 (1.56, 9.23) for 3 FDRs affected. In an absence of FDR family history, increased risk for lung cancer was significant for increasing numbers of affected second-degree relatives (SDR) ranging from 1.41 (1.30, 1.52) for 1 SDR to 4.76(1.55, 11.11) for 4 SDRs. This was also seen in the absense of FDRs and SDRs for affected third-degree relatives (TDR) ranging from 1.18 (1.11, 1.24) for 1 affected TDR to 1.55 (1.03, 2.24) for 4 affected TDRs. RRs were significantly increased with earlier age at diagnosis of a first degree relative, and equivalent risks for maternal compared to paternal history were observed. Conclusion: This study provides unbiased, populationbased estimates of lung cancer risk based on a proband's complete family history that can be 2-5+ times increased. Estimates of RR for lung cancer based on family history are arguably very relevant clinically. The constellation RR estimates presented could serve in individual decision making to direct resource utilization, and could be pivotal in decision making for screening, treatment, and post treatment surveillance. Background: After our recent report that trained dogs can identify the presence of lung cancer (LC) in exhaled air samples of patients with and without large LC(1), we designed a prospective controlled study to investigate if such trained dog can also discriminate between the exhaled gas samples of individuals with and without malignant pulmonary nodules. Method: We collected samples of exhaled air from 30 patients with indeterminate pulmonary nodules before the diagnostic and therapeutic surgery, and from 77 individuals without LC and without pulmonary nodules. Exclusion criteria were other neoplasm, and chemotherapy treatment. Participants refrained to eat, drink and smoke 30 minutes before they exhaled inside a crystal tube filled with hidrophilic and hidrophovic wool and closed with silicon taps, as we used in our previous report. Likewise, the training method of the dog was also based on a progressive prize-dependent learning method. Tubes containing the samples were introduced in wood boxes with an
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